Table 3.
Phenotype | Healthy blood donors | SLE patients | P -value |
---|---|---|---|
CD88, % |
92 ± 3.8 |
77 ± 1 |
≤0.0001 |
CD88, geoMFI |
466 ± 24 |
285 ± 4 |
≤0.0001 |
CD62L, % |
98 ± 0.3 |
98 ± 0.2 |
ns |
CD62L, geoMFI |
1180 ± 64 |
1100 ± 42 |
ns |
CD11b, % |
100 ± 0 |
100 ± 0 |
ns |
CD11b, geoMFI | 9343 ± 578 | 8166 ± 270 | ns |
Comparisons were done between SLE patients and healthy blood donors in regard of the frequency (%) and amount (geometric mean fluorescence intensity (geoMFI) of positive cells) of CD88, CD62L and CD11b on CD10+CD16+ PMN. Values represent mean ± standard error of the mean. The two-sided Mann-Whitney test was used to calculate the level of significance; ns, not significant.